Diaceutics (DXRX) Stock Chart & Stock Price History GBX 128.55 +1.36 (+1.07%) As of 05:25 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Diaceutics Stock Price Performance The Diaceutics (DXRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 3.35%, with a year-to-date return of 4.51%. In the past month, the stock has increased 8.94%, reflecting recent market activity. As of the latest close, Diaceutics traded at GBX 127.19 with a market cap of £107.34 million and volume of 327,040 shares. Five years ago, the stock traded at GBX 163.50, representing a 21.38% decrease over that period. At the time, it had a market cap of £137.45 million and a volume of 13,415 shares. Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.67%1 Month Performance+8.94%3 Month Performance+6.24%Year-To-Date Performance+4.51%1 Year Performance-3.35%5 Year Performance-21.38% DXRX Stock Chart for Monday, July, 21, 2025 DXRX Chart by TradingView Diaceutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025GBX 119GBX 127.19+6.88%GBX 130GBX 125327,040 shs£107.34 million07/17/2025GBX 120.51GBX 119-1.25%GBX 129.90GBX 11953,409 shs£100.43 million07/16/2025GBX 120.38GBX 120.51+0.11%GBX 123GBX 11831,432 shs£101.70 million07/15/2025GBX 119.79GBX 120.38+0.49%GBX 122.70GBX 114106,789 shs£101.59 million07/14/2025GBX 119GBX 119.79+0.66%GBX 120GBX 11461,246 shs£101.10 million07/11/2025GBX 118.40GBX 119+0.51%GBX 120GBX 11312,197 shs£100.43 million07/10/2025GBX 116.33GBX 118.40+1.78%GBX 118.50GBX 114.6556,210 shs£99.92 million07/09/2025GBX 120GBX 116.33-3.06%GBX 118GBX 114.60662,522 shs£98.17 million07/08/2025GBX 114.32GBX 120+4.97%GBX 120GBX 114.5012,299 shs£101.27 million07/07/2025GBX 116.50GBX 114.32-1.87%GBX 120GBX 114.3230,926 shs£96.48 million Get the Latest News and Ratings for DXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025GBX 117GBX 117GBX 120GBX 113176,275 shs£98.74 million07/03/2025GBX 113GBX 117+3.54%GBX 120GBX 113176,275 shs£98.74 million07/02/2025GBX 114GBX 113-0.88%GBX 116.80GBX 11326,247 shs£95.37 million07/01/2025GBX 116GBX 114-1.72%GBX 120GBX 11361,758 shs£96.21 million06/30/2025GBX 119.48GBX 116-2.91%GBX 120GBX 11692,248 shs£97.90 million06/27/2025GBX 118.50GBX 119.48+0.83%GBX 120GBX 117.3672,885 shs£100.83 million06/26/2025GBX 112.50GBX 118.50+5.33%GBX 120GBX 113.11457,621 shs£100.01 million06/25/2025GBX 115GBX 112.50-2.17%GBX 117GBX 112.50170,569 shs£94.94 million06/24/2025GBX 116GBX 115-0.86%GBX 116GBX 112.25169,061 shs£97.05 million06/23/2025GBX 118GBX 116-1.69%GBX 116GBX 114404,149 shs£97.90 million06/20/2025GBX 117.85GBX 118+0.13%GBX 118GBX 116585,993 shs£99.59 million Related Companies ANGLE Stock Chart Abingdon Health Stock Chart Proteome Sciences Stock Chart genedrive Stock Chart GENinCode Stock Chart Verici Dx Stock Chart LungLife AI Stock Chart LLA.L,0P0001T9GN,0 Stock Chart Integrated Diagnostics Stock Chart Allergy Therapeutics Stock Chart Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:DXRX) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
